Differences in the Prevalence of Human Papillomavirus (HPV) in Head and Neck Squamous Cell Cancers by Sex, Race, Anatomic Tumor Site, and HPV Detection Method
Gypsyamber DʼSouza(Johns Hopkins University), Carole Fakhry(Johns Hopkins University), William H. Westra(Mount Sinai Hospital), Harry Quon(Johns Hopkins University), Eleni M. Rettig(Dana-Farber Cancer Institute), William R. Ryan(University of California, San Francisco), Alicia Wentz(Johns Hopkins University), Jeremy D. Richmon(Massachusetts Eye and Ear Infirmary), Nicole Kluz(Johns Hopkins University), Justin A. Bishop(Southwestern Medical Center), Hyunseok Kang(Johns Hopkins University), Ana P. Kiess(Johns Hopkins University), Patrick K. Ha(University of California, San Francisco), David W. Eisele(Sidney Kimmel Comprehensive Cancer Center), Steven J. Wang(University of California, San Francisco), Annemieke van Zante(University of California, San Francisco)
Cited by 159
Related Papers
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in <i>NOTCH1</i>
|Science|2011|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
|Nature Medicine|2018|1k
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
|Cancer Discovery|2016|897